Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Vinay Prasad, a professor at the University of California San Francisco, became a harsh critic of the government’s response ...

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the ...

A gene therapy for Huntington’s disease has a new path toward approval from the Food and Drug Administration after the ouster of several Trump officials, particularly Vinay Prasad, who rejected the ...

“Human life is not disposable, but a precious gift from God, with inherent worth and dignity.” It’s encouraging to learn that the author of those words, Dr. Heidi Overton, is reportedly one of three ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Vinay Prasad in 2016. (Marvin Joseph / The Washington Post via Getty Images file) (Marvin Joseph) The Food and Drug ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Prasad remains a vocal critic of mask mandates and fast-tracked COVID boosters that became controversial issues during pandemic lockdowns. The U.S. Food and Drug Administration announced Tuesday Vinay ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. NEW ORLEANS — Greetings from the home ...

(CNN) — The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and ...